CBIO CIK: 1253689

Crescent Biopharma Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−57.5
FY22:
−46.5
FY23:
−34.9
FY24:
−31.1
FY25:
−71.5
Change from FY21 to FY25
millions USD
FY21:
−0.01
FY22:
−0.08
FY23:
−0.02
FY24:
0.02
FY25:
−72.9
Change from FY21 to FY25
millions USD
FY21:
10.7
FY22:
4.16
FY23:
28.8
FY24:
0.01
FY25:
323
millions USD
FY21:
−46.8
FY22:
−42.4
FY23:
−6.08
FY24:
−31.1
FY25:
179
(positive)
Change from FY21 to FY25
millions USD
FY21:
−57.5
FY22:
−46.5
FY23:
−34.9
FY24:
−31.1
FY25:
−72.5

All amounts in millions USD Data source:SEC EDGAR